Delivery Order SPE2DX22D0010-SPE2D825FHF16
- Not listed
- This delivery order, awarded on July 24, 2025, represents a $2,419.69 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain. The non-competitive delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate...
- This delivery order, awarded on July 23, 2025, represents a $3,784.44 firm fixed-price contract issued by the Defense Logistics Agency Medical Supply Chain to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supply delivery. The contract is non-competitive with no set-aside designation and is expected to be completed by July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical...
- This delivery order, awarded July 23, 2025, represents a $1,651.68 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation, indicating it was...
- This delivery order, awarded July 21, 2025, represents a $61,455.73 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is non-competitive and has an ultimate completion date of July 22, 2025. This award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- This delivery order, awarded July 21, 2025, represents a $53,474.62 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract, which concludes July 22, 2025, was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, PA. This delivery...
- This delivery order, awarded on July 21, 2025, represents a $39,780.34 firm fixed-price contract to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supply delivery. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and is set to be completed by July 22, 2025. AmerisourceBergen will perform work from its Corporate Office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside...
- This delivery order, awarded July 25, 2025, represents a $10,277.41 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) under the Defense Logistics Agency's Medical Supply Chain program. As a child contract under AmerisourceBergen's larger $999.99 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical running through December 2026, this delivery order fulfills the company's role as a pharmaceutical prime vendor for military and federal...
- This delivery order, awarded on July 27, 2025, represents a $1,104.80 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Medical Supply Chain, a defense-focused federal agency. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 through December 2026. This delivery order was competitively awarded without set-aside...
- This delivery order, awarded July 18, 2025, represents a $2.4 million firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is not set-aside and was competitively awarded, with an ultimate completion date of July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform work at its Corporate Office location and serve as the prime contractor for this...
- This delivery order, awarded on July 22, 2025, represents a $14,931.36 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. This award is not...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHF16Delivery Order
This delivery order, awarded July 26, 2025, represents a $391,359.93 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The non-competitive delivery order is set to conclude by July 28, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive portfolio of pharmaceutical products and medical commodities to support federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities globally to support military healthcare programs. The contract falls within the DLA's Pharmaceutical Prime Vendor Global Program framework, which anticipates multiple regional awards across several contractors to ensure robust pharmaceutical supply chain support for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $391.4k | 7/26/25 |